TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters
about
Tumor treating fields: concept, evidence and future.Tumor treating fields: a new frontier in cancer therapy.Recurrent malignant gliomas.Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastomaBiological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiationThe Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells.Biological activity of tumor-treating fields in preclinical glioma models.Electrical stimulation towards melanoma therapy via liquid metal printed electronics on skin.Silver nanoparticles increase cytotoxicity induced by intermediate frequency low voltages.Gold-gold sulfide nanoshell as a novel intensifier for anti-tumor effects of radiofrequency fieldsTumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell linesDetermining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields).Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.
P2860
Q34183195-DB60F3F9-0339-44AF-B223-4BBD0FD0B042Q34343822-D029FDCE-790A-48EA-9D2B-C1472F706F2DQ34438507-09F9A905-EC7D-4422-8F11-1E69DA14C340Q35970661-324C0EE1-1FF1-4DDA-9248-AF672E0A8A13Q37641759-5A2C1515-7230-4704-8B4E-EFA0D976E6A0Q38612761-448BF66E-2A34-4F25-9AA4-54A7D63DBF44Q38730119-ED909346-96E4-460B-A10C-AF086A4645B4Q38828969-2267EFBD-7D32-4CB8-92E9-098831234F1DQ38849007-43A98B2F-C997-4A89-86FE-12E6E639A185Q38988000-1AA9C5DF-FB08-46C4-96F5-CDB274247BCDQ41928500-3D007B62-11AA-4F8A-8690-4ED0F29AD743Q42292362-46E6E65F-8B1D-4678-B24B-8965215F982DQ42361869-3E407FF2-3ACD-4026-B408-45C82E5662ACQ53788180-699FABA7-94BE-45B1-9E79-7286D30F86C5
P2860
TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
TTFields alone and in combinat ...... over-express ABC transporters
@ast
TTFields alone and in combinat ...... over-express ABC transporters
@en
TTFields alone and in combinat ...... over-express ABC transporters.
@nl
type
label
TTFields alone and in combinat ...... over-express ABC transporters
@ast
TTFields alone and in combinat ...... over-express ABC transporters
@en
TTFields alone and in combinat ...... over-express ABC transporters.
@nl
prefLabel
TTFields alone and in combinat ...... over-express ABC transporters
@ast
TTFields alone and in combinat ...... over-express ABC transporters
@en
TTFields alone and in combinat ...... over-express ABC transporters.
@nl
P2093
P2860
P356
P1433
P1476
TTFields alone and in combinat ...... over-express ABC transporters
@en
P2093
Eilon D Kirson
Esther Shmueli
Rosa S Schneiderman
Yoram Palti
P2860
P2888
P356
10.1186/1471-2407-10-229
P407
P577
2010-05-23T00:00:00Z
P5875
P6179
1030456365